Both studies describe cancer drivers at similar frequencies and similar tumor manifestations (for example, BRCA2 mutations in metastases), but Suehara et al suggest that co‐amplifications of the regions PDGFRA–KIT and VEGFA–CCND3 are mutually exclusive, which our data contradict. This evidence concerns the gene BRCA2 and cancer.